Lifepoint, Inc. (LFP)

[Chrisau]

Looks like they're BK.


ACCESSION NUMBER: 0001019687-05-001204
CONFORMED SUBMISSION TYPE: 8-K
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20050428
ITEM INFORMATION: Other Events
FILED AS OF DATE: 20050429
DATE AS OF CHANGE: 20050429

FILER:

COMPANY DATA:
COMPANY CONFORMED NAME: LIFEPOINT INC
CENTRAL INDEX KEY: 0000910523
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330539168
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331

FILING VALUES:
FORM TYPE: 8-K
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12362
FILM NUMBER: 05784534

BUSINESS ADDRESS:
STREET 1: 1205 S. DUPONT ST.
CITY: ONTARIO
STATE: A6
ZIP: 91761
BUSINESS PHONE: [phone]

MAIL ADDRESS:
STREET 1: 1205 S. DUPONT ST.
CITY: ONTARIO
STATE: A6
ZIP: 91761

FORMER COMPANY:
FORMER CONFORMED NAME: U S DRUG TESTING INC
DATE OF NAME CHANGE: 19930811
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>lifepoint_8k-042805.txt
<TEXT>
<PAGE>

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) April 28, 2005

LIFEPOINT, INC.
---------------

(Exact name of registrant as specified in its charter)

DELAWARE #33-0539168
- --------------------------------------------------------------------------------
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification Number)

1205 S. DUPONT STREET, ONTARIO, CALIFORNIA 91761
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)

[phone]
- --------------------------------------------------------------------------------
Registrant's Telephone Number, Including Area Code

---------------

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR240.13e-4(c))

================================================================================

<PAGE>


ITEM 8.01 OTHER EVENTS.

On April 14, 2005, LifePoint, Inc. (the "Company") announced that it had enough
cash on hand to support its operations through April 27, 2005. The Company was
unsuccessful in obtaining additional financing to fund its continuing
operations. As a result, the Company assigned its assets in trust, for the
benefit of all of the Company's creditors, to the Insolvency Services Group,
Inc. effective April 28, 2005.


<PAGE>


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned therein to be duly authorized.


LIFEPOINT, INC.
(Registrant)

Date: April 28, 2005 By /s/ Gerry C. Braun
-----------------------
Gerry C. Braun
Chief Financial Officer
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----

[Chrisau]

13 Feb 2003, 06:03 PM EST

FOR IMMEDIATE RELEASE
LifePoint, Inc. Changes the Date of
Its Third Quarter Fiscal 2003 Conference Call
ONTARIO, CA, February 13, 2003 – LifePoint, Inc. (AMEX: LFP), announced that due to the
fact that its auditors have not completed their review of the quarter ended December 31, 2002 the
conference call has been rescheduled for Thursday, February 20, 2003 at 9:00 a.m., EST (6:00
a.m. PST), with Linda H. Masterson, President and CEO, and Michele Clark, Controller and
Chief Accounting Officer.
What: LifePoint, Inc.’s Fiscal 2003 Third Quarter Conference Call
When: Thursday, February 20, 2003, 9:00 a.m. EST
Web address: www.streetevents.com, www.companyboardroom.com, or
www.LifePointInc.com
Dial-in numbers: 1-800-915-4836 (domestic) and 1-973-317-5319 (international)
Contact: Lester Rosenkrantz, Cameron Associates, 212-245-8800 x212
If you are unable to participate, an audio digital replay of the call will be available from
Thursday, February 20th at 11 a.m. EST until Midnight EST on February 27th by dialing 1-800-
428-6051 (domestic) or 973-709-2089 (international) using confirmation code #286161. A web
archive will be available for 30 days at www.streetevents.com, www.companyboardroom.com ,
or www.LifePointInc.com. The company will issue its quarterly letter to shareholders following
the conference call.
About LifePoint, Inc.
LifePoint, Inc., a leader in non-invasive drug diagnostic technologies and solutions, has
developed, manufactures and markets the IMPACT Test System – a rapid diagnostic testing,
screening and drug monitoring device for use in the workplace, home health care, ambulances,
pharmacies and law enforcement. LifePoint’s patented and proprietary technologies for the use of
saliva as a non-invasive, blood-comparable test specimen, used in conjunction with the flow
immunosensor technology licensed from the United States Navy, has allowed LifePoint to
develop a broadly applicable, rapid, on-site diagnostic test system. The first product
simultaneously detects drugs of abuse and alcohol, with the initial three target markets estimated
to be over $1.6 billion.
LifePoint® and IMPACT® are trademarks of LifePoint, Inc.

[Chrisau]

NEWS

LifePoint, Inc. Invites You to Join its Third Quarter Fiscal 2003 Conference Call
10 Feb 2003, 11:15am ET
E-mail or Print this story
- - - - -

ONTARIO, Calif.--(BUSINESS WIRE)--Feb. 10, 2003--LifePoint, Inc.
(AMEX:LFP), announced that in conjunction with the Company's fiscal
2003 third quarter earnings release, you are invited to listen to its
conference call on Friday, February 14, 2003 at 9:00 a.m., EST (6:00
a.m. PST), with Linda H. Masterson, President and CEO and Michele
Clark, Controller and Chief Accounting Officer.

What: LifePoint, Inc.'s Fiscal 2003 Third Quarter Conference Call

When: Friday, February 14, 2003, 9:00 a.m. EST

Web address: www.streetevents.com, www.companyboardroom.com, or
www.LifePointInc.com

Dial-in numbers: 1-800-915-4836 (domestic) and 1-973-317-5319
(international)

Contact: Lester Rosenkrantz, Cameron Associates, 212-245-8800 x212

If you are unable to participate, an audio digital replay of the
call will be available from Friday, February 14th at 11 a.m. EST until
Midnight EST on February 21st by dialing 1-800-428-6051 (domestic) or
973-709-2089 (international) using confirmation code #286161. A web
archive will be available for 30 days at www.streetevents.com,
www.companyboardroom.com , or www.LifePointInc.com. The company will
issue its quarterly letter to shareholders following the conference
call.

About LifePoint, Inc.

LifePoint, Inc., a leader in non-invasive drug diagnostic
technologies and solutions, has developed, manufactures and markets
the IMPACT Test System - a rapid diagnostic testing, screening and
drug monitoring device for use in the workplace, home health care,
ambulances, pharmacies and law enforcement. LifePoint's patented and
proprietary technologies for the use of saliva as a non-invasive,
blood-comparable test specimen, used in conjunction with the flow
immunosensor technology licensed from the United States Navy, has
allowed LifePoint to develop a broadly applicable, rapid, on-site
diagnostic test system. The first product simultaneously detects drugs
of abuse and alcohol, with the initial three target markets estimated
to be over $1.6 billion.
LifePoint(R) and IMPACT(R) are trademarks of LifePoint, Inc.


CONTACT: LifePoint, Inc.
Linda H. Masterson, 909/418-3000 x 400
e-mail: [e-mail]
Web site: www.LifePointInc.com
or
Cameron Associates
Lester Rosenkrantz, 212/245-8800 ext. 212
e-mail: [e-mail]

KEYWORD: CALIFORNIA
INDUSTRY KEYWORD: MEDICAL DEVICES ADVISORY CONFERENCE CALLS
SOURCE: LifePoint, Inc.

[Surelock Homes]

By: aol_bites $
21 Nov 2002, 12:36 AM EST Msg. 10947

other mentions

http://www.njcops.com/page.php?page=179

http://www.ncadd.com/techcenter/saliva_screening.html
http://www.ncadd.com/techcenter/detecting/providers/estlife.html

http://www.biospace.com/ccis/detail.cfm?ClinicalID=343604

http://www.wired.com/wired/archive/9.10/streetcred.html?pg=13

http://www.biobn.com/
http://www.biobn.com/repository/ir/lifepoint/ir_lifepoint.wmv

http://www.techtran.co.jp/techtr_j/reporta/diagnost1.html

http://www.monitor.ca/monitor/issues/vol9iss5/netstuff.html

http://www.buscom.com/biotech/B149.html

http://www.indegene.com/Psy/Home/indPsy_Ind_News_19-08-2001_1.asp

http://www.mindbranch.com/catalog/print_product_page.jsp?code=R2-543

=====================
fda:

http://www.fda.gov/ohrms/dockets/dailys/01/Feb01/022001/c000002.pdf

http://www.fda.gov/ohrms/dockets/ac/00/minutes/3666m1.pdf

http://www.fda.gov/default.htm

http://63.75.126.224/Google/fda_search.pl?client=fdagov&site=fdagov&restrict=&searchsele....

=====================
news:

[about pop sci]
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=KTVB_MAG.story&STORY=/www/story/11-11-2002/000...

http://corporate.findlaw.com/industry/health/case.html

http://www.psiquiatria24x7.com/news/detail.jhtml;jsessionid=EJB1CL1M4X0K2CUCEQUSF3Q?itemname=p111102....

=================